Arikawa M - Search Results

1

Ischemia-induced translocation of protein kinase C-epsilon mediates cardioprotection in the streptozotocin-induced diabetic rat.

Ooie T, Takahashi N, Nawata T, Arikawa M, Yamanaka K, Kajimoto M, Shinohara T, Shigematsu S, Hara M, Yoshimatsu H, Saikawa T. Ooie T, et al. Among authors: arikawa m. Circ J. 2003 Nov;67(11):955-61. doi: 10.1253/circj.67.955. Circ J. 2003. PMID: 14578604 Free article.

2

Enhanced inhibition of L-type calcium currents by troglitazone in streptozotocin-induced diabetic rat cardiac ventricular myocytes.

Arikawa M, Takahashi N, Kira T, Hara M, Saikawa T, Sakata T. Arikawa M, et al. Br J Pharmacol. 2002 Jul;136(6):803-10. doi: 10.1038/sj.bjp.0704757. Br J Pharmacol. 2002. PMID: 12110604 Free PMC article.

3

Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart.

Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, Yamanaka K, Hara M, Shimada T, Sakata T. Ooie T, et al. Among authors: arikawa m. Circulation. 2001 Oct 9;104(15):1837-43. doi: 10.1161/hc3901.095771. Circulation. 2001. PMID: 11591623

4

Attenuated inhibition of L-type calcium currents by troglitazone in fructose-fed rat cardiac ventricular myocytes.

Arikawa M, Takahashi N, Kira T, Hara M, Yoshimatsu H, Saikawa T. Arikawa M, et al. J Cardiovasc Pharmacol. 2004 Jul;44(1):109-16. doi: 10.1097/00005344-200407000-00015. J Cardiovasc Pharmacol. 2004. PMID: 15175565

5

Radiofrequency catheter ablation from the left sinus of Valsalva in a patient with idiopathic ventricular tachycardia.

Takahashi N, Saikawa T, Oribe A, Ooie T, Iwao T, Arikawa M, Nakagawa M, Hara M, Takakura T, Shimoike E, Kaji Y, Ito M, Sakata T. Takahashi N, et al. Among authors: arikawa m. Pacing Clin Electrophysiol. 2000 Jul;23(7):1172-5. doi: 10.1111/j.1540-8159.2000.tb00921.x. Pacing Clin Electrophysiol. 2000. PMID: 10914376

6

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.

Kanaoka K, Onoue K, Terasaki S, Nakano T, Nakai M, Sumita Y, Hatakeyama K, Terasaki F, Kawakami R, Iwanaga Y, Miyamoto Y, Saito Y; Japanese Registry of Fulminant Myocarditis Investigators. Kanaoka K, et al. Circulation. 2022 Nov 8;146(19):1425-1433. doi: 10.1161/CIRCULATIONAHA.121.058869. Epub 2022 Sep 27. Circulation. 2022. PMID: 36164974

7

Novel mutation of the DAX1 gene in a patient with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism.

Hamaguchi K, Arikawa M, Yasunaga S, Kakuma T, Fukagawa K, Yanase T, Nawata H, Sakata T. Hamaguchi K, et al. Among authors: arikawa m. Am J Med Genet. 1998 Feb 26;76(1):62-6. doi: 10.1002/(sici)1096-8628(19980226)76:1<62::aid-ajmg11>3.0.co;2-n. Am J Med Genet. 1998. PMID: 9508067

8

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Preserved Trial Investigators. Anker SD, et al. N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27. N Engl J Med. 2021. PMID: 34449189 Clinical Trial.

9

Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.

Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Naito R, et al. JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561. JAMA Cardiol. 2022. PMID: 35704345 Free PMC article. Clinical Trial.

10

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting: Insights From the AFIRE Trial.

Matoba T, Yasuda S, Kaikita K, Akao M, Ako J, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Matoba T, et al. JACC Cardiovasc Interv. 2021 Nov 8;14(21):2330-2340. doi: 10.1016/j.jcin.2021.07.045. JACC Cardiovasc Interv. 2021. PMID: 34736731 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page